TreatmentTrends®:  Biologics in Rheumatology

A Quarterly Report Package Providing Insight into the Management of RA Patients by Rheumatologists

Study Overview:

TreatmentTrends are syndicated reports that provide longitudinal information on market dynamics. This series of four reports provides insight into practice patterns, attitudes and perceptions, current product use and future projections. It evaluates perceived product advantages and disadvantages, as well as sales and marketing efforts of key players. Emphasis is on current biologic products used in the management of RA.

Methodology:

Physicians complete a self-administered internet survey. The methodology is quantitative with several open-ended questions for qualitative feedback.

Sample Frame:

Each report will highlight responses from a random sample of 150 board-certified Rheumatologists all participating Rheumatologists will have at least 50 patients being treated with biologic agents for RA.

Timing:

TreatmentTrends in Rheumatology is fielded and published quarterly. 2010 Publication dates are: April 12, July 12, October 11, and December 31st.

Deliverables:

In addition to the final report following each wave, a complete set of frequency tables, summary statistics, and cross-tabulations will be provided. Clients will also receive a customized report with information from their proprietary questions (each client has the option to include up to three proprietary questions). Onsite or web-cast presentations are available upon request at no charge.